Improving the use of research evidence in guideline development: 4. Managing conflicts of interests
- PMID: 17140441
- PMCID: PMC1693552
- DOI: 10.1186/1478-4505-4-16
Improving the use of research evidence in guideline development: 4. Managing conflicts of interests
Abstract
Background: The World Health Organization (WHO), like many other organisations around the world, has recognised the need to use more rigorous processes to ensure that health care recommendations are informed by the best available research evidence. This is the fourth of a series of 16 reviews that have been prepared as background for advice from the WHO Advisory Committee on Health Research to WHO on how to achieve this.
Objectives: We reviewed the literature on conflicts of interest to answer the following questions: 1. What is the best way to obtain complete and accurate disclosures on financial ties and other competing interests? 2. How to determine when a disclosed financial tie or other competing interest constitutes a conflict of interest? 3. When a conflict of interest is identified, how should the conflict be managed? 4. How could conflict of interest policies be enforced?
Methods: We searched PubMed, the Cochrane Methodology Register and selectively searched for the published policies of several organizations, We did not conduct systematic reviews ourselves. Our conclusions are based on the available evidence, consideration of what WHO and other organisations are doing and logical arguments.
Key questions and answers: What is the best way to obtain complete and accurate disclosures on financial ties and other competing interests? Although there is little empirical evidence to guide the development of disclosure forms, minimal or open-ended formats are likely to be uninformative. We recommend the development of specific, detailed, structured forms that solicit as much information as possible about the nature and extent of the competing interests. How to determine when a disclosed financial tie or other competing interest constitutes a conflict of interest?* There is no empirical evidence to suggest that explicit criteria are preferable to ad hoc committee decisions when deciding if a disclosed financial tie is a conflict of interest. However, explicit criteria may make decision-making easier. When a conflict of interest is identified, how should the conflict be managed? Descriptive studies suggest that appropriate management strategies are best determined on a case-by-case basis. Thus, WHO should use a wide range of management strategies to address disclosed conflicts of interest, with public disclosure of conflicts associated with each meeting as a minimum and recusal of conflicted individuals as the other extreme. How could conflict of interest policies be enforced? Although there are no empirical studies of the enforcement of conflict if interest policies, descriptive studies of other organizations and institutions suggest that WHO convene a standing committee to review all financial disclosure statements prior to the commencement of committee meetings/hearings and to make management recommendations when necessary. A standard policy requiring all financial ties to be made public (i.e., recorded into the meeting minutes) should reduce the number of problematic cases. In instances where the conflicts seem intractable, a recommendation of recusal may be necessary to protect the greater interests of WHO and its constituents.
Similar articles
-
Guideline funding and conflicts of interest: article 4 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.Proc Am Thorac Soc. 2012 Dec;9(5):234-42. doi: 10.1513/pats.201208-057ST. Proc Am Thorac Soc. 2012. PMID: 23256165 Review.
-
Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings.JAMA. 2006 Apr 26;295(16):1921-8. doi: 10.1001/jama.295.16.1921. JAMA. 2006. PMID: 16639051
-
Improving the use of research evidence in guideline development: 1. Guidelines for guidelines.Health Res Policy Syst. 2006 Nov 21;4:13. doi: 10.1186/1478-4505-4-13. Health Res Policy Syst. 2006. PMID: 17118181 Free PMC article.
-
Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations.Cochrane Database Syst Rev. 2020 Dec 8;12(12):MR000040. doi: 10.1002/14651858.MR000040.pub3. Cochrane Database Syst Rev. 2020. PMID: 33289919 Free PMC article.
-
Improving the use of research evidence in guideline development: 2. Priority setting.Health Res Policy Syst. 2006 Nov 29;4:14. doi: 10.1186/1478-4505-4-14. Health Res Policy Syst. 2006. PMID: 17134481 Free PMC article.
Cited by
-
Gestion des conflits d’intérêts durant l’élaboration de lignes directrices en santé.CMAJ. 2021 Mar 1;193(9):E324-E330. doi: 10.1503/cmaj.200651-f. CMAJ. 2021. PMID: 33649178 Free PMC article. French. No abstract available.
-
Psychiatry: from interest in conflicts to conflicts of interest.World Psychiatry. 2007 Feb;6(1):27-9. World Psychiatry. 2007. PMID: 17342218 Free PMC article. No abstract available.
-
Community participation for reproductive, maternal, newborn and child health: insights from the design and implementation of the BornFyne-prenatal management system digital platform in Cameroon.Front Digit Health. 2023 Aug 17;5:1218641. doi: 10.3389/fdgth.2023.1218641. eCollection 2023. Front Digit Health. 2023. PMID: 37664872 Free PMC article.
-
Evidence-informed health policy 4 - case descriptions of organizations that support the use of research evidence.Implement Sci. 2008 Dec 17;3:56. doi: 10.1186/1748-5908-3-56. Implement Sci. 2008. PMID: 19091110 Free PMC article.
-
Evidence-based guidelines: Improving AGREEment on consistence evaluation.J Bone Oncol. 2012 Apr 30;1(1):30-4. doi: 10.1016/j.jbo.2012.04.001. eCollection 2012 Jun. J Bone Oncol. 2012. PMID: 26909252 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous